HPV vaccination among French girls and women aged 14–23 years and the relationship with their mothers’ uptake of Pap smear screening: A study in general practice

Vaccine - Tập 31 - Trang 5243-5249 - 2013
D. Lutringer-Magnin1,2, C. Cropet3, G. Barone1, G. Canat3, J. Kalecinski4, Y. Leocmach5, P. Vanhems6,2, F. Chauvin4, C. Lasset3,2
1Centre Léon-Bérard, Lyon, France
2Université Lyon 1, CNRS UMR 5558, France
3Centre Léon Bérard, Lyon, France
4Institut de Cancérologie Lucien Neuwirth, CIC-EC 3 Inserm, IFR 143, Saint-Etienne, France
5Sanofi Pasteur MSD, Lyon, France
6Hospices Civils de Lyon, Lyon, France

Tài liệu tham khảo

Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516 Bosch, 2008, Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia, Vaccine, 26, K1, 10.1016/j.vaccine.2008.05.064 Institut de Veille Sanitaire, 2012 2012 Institut de veille Sanitaire, 2012, Calendrier des vaccinations et recommandations vaccinales 2012 selon l’avis du haut conseil de la santé publique (2012 vaccination schedule and recommendations from the « Haut Conseil de la santé publique » in France), Bull Epidémiol Hebd, 14–15, 163 Haut Conseil de la santé publique, 2010 Trim, 2012, Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011, Obstet Gynecol Int, 2012, 921236, 10.1155/2012/921236 Kessels, 2012, Factors associated with HPV vaccine uptake in teenage girls: a systematic review, Vaccine, 30, 3546, 10.1016/j.vaccine.2012.03.063 Schiller, 2012, A review of clinical trials of human papillomavirus prophylactic vaccines, Vaccine, 30, F123, 10.1016/j.vaccine.2012.04.108 Naleway, 2012, Reported adverse events in young women following quadrivalent human papillomavirus vaccination, J Womens Health, 21, 425, 10.1089/jwh.2011.2895 Schwarz, 2012, Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10-14 years, J Adolesc Health, 50, 187, 10.1016/j.jadohealth.2011.11.004 Slade, 2009, Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine, J Am Med Assoc, 302, 750, 10.1001/jama.2009.1201 Klein, 2012, Safety of quadrivalent human papillomavirus vaccine administered routinely to females, Arch Pediatr Adolesc Med, 166, 1140, 10.1001/archpediatrics.2012.1451 Chao, 2012, Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine, J Intern Med, 271, 193, 10.1111/j.1365-2796.2011.02467.x Chao, 2009, Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls, Am J Public Health, 99, 1137, 10.2105/AJPH.2008.147876 Lefevere, 2011, Like mother, like daughter? Mother's history of cervical cancer screening and daughter's human papillomavirus vaccine uptake in Flanders (Belgium), Vaccine, 29, 8390, 10.1016/j.vaccine.2011.08.039 Monnat, 2013, Is there an association between maternal pap test use and adolescent human papillomavirus vaccination?, J Adolesc Health, 52, 212, 10.1016/j.jadohealth.2012.05.015 Haesebaert, 2012, French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14–18 year old daughters: a quantitative-qualitative study, BMC Public Health, 12, 1034, 10.1186/1471-2458-12-1034 Lutringer-Magnin, 2011, Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing, Vaccine, 29, 5322, 10.1016/j.vaccine.2011.05.006 Institut National de Prévention et d’Education pour la santé, 2005, 331 Rouzier, 2010, Coverage and compliance of human papilloma virus vaccines in Paris: demonstration of low compliance with non-school-based approaches, J Adolesc Health, 47, 237, 10.1016/j.jadohealth.2010.04.006 Laz, 2012, An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010, Vaccine, 30, 3534, 10.1016/j.vaccine.2012.03.067 Ogilvie, 2010, A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt, PLoS Med, 7, e1000270, 10.1371/journal.pmed.1000270 Agius, 2010, Human papillomavirus and cervical cancer: gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students, Vaccine, 28, 4416, 10.1016/j.vaccine.2010.04.038 Forster, 2010, Understanding adolescents’ intentions to have the HPV vaccine, Vaccine, 28, 1673, 10.1016/j.vaccine.2009.11.082 Smith, 2011, Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls, BMC Public Health, 11, 645, 10.1186/1471-2458-11-645 Dempsey, 2010, Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system, Vaccine, 28, 989, 10.1016/j.vaccine.2009.10.133 Niccolai, 2011, Racial/ethnic and poverty disparities in human papillomavirus vaccination completion, Am J Prev Med, 41, 428, 10.1016/j.amepre.2011.06.032 Widdice, 2011, Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses, Pediatrics, 127, 77, 10.1542/peds.2010-0812 Chao, 2009, Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization, Mayo Clin Proc, 84, 864, 10.4065/84.10.864 Dempsey, 2012, Follow-up analysis of adolescents partially vaccinated against human papillomavirus, J Adolesc Health, 50, 421, 10.1016/j.jadohealth.2011.08.017 Lau, 1990, Development and change of young adults’ preventive health beliefs and behavior: influence from parents and peers, J Health Soc Behav, 31, 240, 10.2307/2136890 Ashok, 2012, Recency of Pap testing and future testing plans among women aged 18–64: analysis of the 2007 Health Information National Trends Survey, J Womens Health, 21, 705, 10.1089/jwh.2012.3562 Lofters, 2011, Predictors of low cervical cancer screening among immigrant women in Ontario, Canada, BMC Womens Health, 11, 20, 10.1186/1472-6874-11-20 Jain, 2009, Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006, J Adolesc Health, 44, 561, 10.1016/j.jadohealth.2008.10.143 Brewer, 2011, Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area, Sex Transm Dis, 38, 197, 10.1097/OLQ.0b013e3181f12dbf Reiter, 2010, Statewide HPV vaccine initiation among adolescent females in North Carolina, Sex Transm Dis, 37, 549, 10.1097/OLQ.0b013e3181d73bf8 Roberts, 2011, Human papillomavirus vaccination and social inequality: results from a prospective cohort study, Epidemiol Infect, 139, 400, 10.1017/S095026881000066X Chao, 2010, Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization, Am J Epidemiol, 171, 357, 10.1093/aje/kwp365 Lutringer-Magnin, 2013, Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status, Eur J Public Health, 10.1093/eurpub/ckt018